Two patient support programs have been suspended in Ukraine – «Therapy Plus' and “Together”
📍This means that patients with cardiac, endocrine, pulmonary and hepatic diseases They can no longer receive medicines at low prices.
▪️“Therapy Plus” (cardiology, endocrinology, pulmonology) has been stopped from 25.02.2025.
▪️“Together” (liver treatment, in particular, “Hepral”) has stopped on 23.02.2025.
⚠️Why?
All through CMU Resolution No. 168which has changed the rules of activity of the pharmaceutical market.
💬What do patients and experts say?
▪️The new regulation can lead to deficiency of important drugs.
▪️The programs have been created by international pharmaceuticals, and now manufacturers do not guarantee their restoration.
If you think about this situation, you can share them in the comments.
DUST⚡️Ukraine | Send the news
